SEC Filings | Landos Biopharma

Filing date	Form	Description	View
05/24/23	4	Statement of changes in beneficial ownership of securities	0001209191-23-031947.pdf 0001209191-23-031947.rtf 0001209191-23-031947.xls View HTML
05/12/23	8-K	Report of unscheduled material events or corporate event	0000950170-23-021516.pdf 0000950170-23-021516.rtf 0000950170-23-021516.xls EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT View HTML
05/12/23	10-Q	Quarterly report which provides a continuing view of a company's financial position	0000950170-23-021517.pdf 0000950170-23-021517.rtf 0000950170-23-021517.xls EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT View HTML
04/19/23	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0000950170-23-013359.pdf 0000950170-23-013359.rtf 0000950170-23-013359.xls View HTML
04/19/23	ARS	An annual report to security holders	0000950170-23-013360.pdf 0000950170-23-013360.rtf View HTML
04/10/23	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	0000950170-23-012301.pdf 0000950170-23-012301.rtf 0000950170-23-012301.xls View HTML
03/30/23	SC 13D/A	An amendment to a SC 13D filing	0001193125-23-085693.pdf 0001193125-23-085693.rtf 0001193125-23-085693.xls View HTML
03/30/23	SC 13D/A	An amendment to a SC 13D filing	0001193125-23-085796.pdf 0001193125-23-085796.rtf 0001193125-23-085796.xls View HTML
03/23/23	8-K	Report of unscheduled material events or corporate event	0000950170-23-009332.pdf 0000950170-23-009332.rtf 0000950170-23-009332.xls EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT View HTML
03/23/23	10-K	Annual report which provides a comprehensive overview of the company for the past year	0000950170-23-009334.pdf 0000950170-23-009334.rtf 0000950170-23-009334.xls EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT View HTML

Data provided by Kaleidoscope.